Cardiac secretion of atrial and brain natriuretic peptides in acute ischaemic heart failure in pigs: Effect of angiotensin II receptor antagonism

Clinical Physiology

Volumn 17, Issue 4, 1997, Pages 389-400

  Klinge, R ^a   Djoseland O ^b   Karlberg, B E ^c   Hall, C ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Angiotensin II receptor antagonism; Atrial natriuretic peptide; Brain natriuretic peptide; Left ventricular failure

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANGIOTENSIN RECEPTOR; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE DERIVATIVE; LOSARTAN; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART PRELOAD; ISCHEMIC HEART DISEASE; LEFT CORONARY ARTERY; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SWINE;

EID: 0030759563     PISSN: 01445979     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2281.1997.04343.x     Document Type: Article

References (32)

1. BLOCH K., SeIDMAN J. G., NAFTILAN J. D., FALLON J. T. & SEIDMAN C. E. (1986) Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell. 47 (5), 695-702.
2. BLOOR C. M., WHITE F. C. & LAMMERS R. J. (1986) Cardiac ischemia and coronary blood flow in swine. In: Swine in cardiovascular research (ed. Stanton H.C) 2, 87-104.
3. CROZIER I., IKRAM H., AWAN N. CLELAND J., STEPHEN N., DICKSTCIN K., FREY M., YOUNGJ J., KLINGER G., MAKRIS L. & RUCINSKA E. (1995) Losartan in heart failure. Hemodynamic effects and tolerability. Circulation, 91 (3), 691-697.,
4. DEBOLD A. J., BORENSTEIN H. B., VERKSS A. T. & SONNENBERG H. (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci, 28,89-94.
5. DICKSTEIN K., CHANG P., WILLENHEIMER R., HAUNSO S., REMES J., HALL C. & KJEKSHUS J. (1995) Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure. J Am Coll Cardiol, 26 (2), 438-45.
6. GANZ W., TAMURA K., MARCUS H. S., DONOSO R., YOSHIDA S. & SWAN H. J. C. (1971) Measurement of coronary sinus blood flow by continous thermodilution in man. Circulation. XLI. 181-195.
7. GOTTLIEB S. S., DICKSTEIN K., FLECK E., KOSTIS J., LEVINE T. B., LEJEMTEL T. & DEKOCK M. (1993) Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation, 88 (4), 1602-1609.
8. GUTKOWSKA J., HORKY K., SCHIFFRIN E. L., THIBAULT G., GARCIA R., DE LEAN A., HAMET P., TRKMBLAY J., ANAND-SRIVASTAVA M. B., JANUSZEWICA P., GFNEST J. & CANTIN M. (1986) Atrial natriurctic factor: radioimmunoassay and effects on adrenal and pituitary glands. Fed Proc, 45 (7), 2101-2105.
9. HALL C. & KARLBERG B. E. (1986) Plasma concentrations of angiotensin II and aldosterone during acute left ventricular failure in the dog. Effect of converting enzyme inhibition. Res Exp Med. 186, 387-395.
10. HALL C., HEVRØY O., KLØW N. E. & SMISETH O. (1988) Plasma concentrations of atrial natriuretic factor in acute left ventricular failure in the dog. Res Exp Med. 188, 443-450.
11. HALL C., AADERGE L. & STOKKE O. (1995) In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite fur its use as a biochemical parameter of atrial pressure in clinical routine. Circulation, 91, 911.
12. HAUG C., METZELE A., KOCHS M., HOMBACH V. & GRIÜNKRT A. (1993) Plasma brain natriuretic peptide and atrial natriuretic- peptide concentrations correlate with left ventricular end-diastolic pressure. Clin Cardiol. 16, 553-557.
13. HINO J., TATHYAMA H., MINAMINO N., KANGAWA K. & MATSUO H. (1990) Isolation and identification of human brain natriuretic peptidcs in cardiac atrium. Biochem Biophys Res Comm, 167 (2), 693-700.
14. HORIO T., SHIMADA K., KOHNO M., YOSHIMURA T., KAWARABAYASHI T., YASUNARI K., MURAKAWA K., YOKOKAWA K., IKEDA M., FUKCI T. & TAKKDA T. (1993) Serial changes in atr7ial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. Am Heart J, 126 (2), 293-299.
15. ITOH H., NAKAO K., SUGAWARA A., SAITTO Y., MUKOYAMA M., MORN N., YAMADA T., SHIONO S., ARAI H., HOSODA K. & IMURA M. (1988) Gamma-atrial natriuretic polypuptide (gammaANP)-derived peptides in human plasma: cosecretion of N-terminal gammaANP fragment and alphaANP. J Clin Endocrinol Metab, 67, 429-437.
16. KAMBAYASHI Y., NAKAO K., MUKUYAMA M., SAITO Y., OGAWA Y., SHIONO S., INOUYE K., YOSHIDA N. & IMURA H. (1990) Isolation and sequence determination of human brain natriuretic peptide in human atrium, FEBS Lett. 259, 341-345.
17. KOHNO M., HORIO T., TODA T., AKIOKA K., TAHARA A., TERAOAKI M., TAKEUCHI K., KURIHARA N. & TAKKDA T. (1992) Cosecretion of atrial and brain natriuretic peptides during supraventricular tachyarrhytmias. Am Heart J. 123 (5), 1382-1384.
18. MAIHISHN P., HALL C. & SIMONSEN S. (1993) Comparative study of atrial peptides ANF (1-98) and AMF (99-126) as diagnostic markers of atrial distension in patients with cardiac disease. Scand J Clin Lab Invest.53.41-49.
19. MORITA E., YASUE H., YOSHIMURA M., OGAWA H., JOUCASAKI M., MAIWAIARA T., MI'KOVAMA M, & N AKAO K. (1993) Increased plasma levels of Brain Natriuretic Peptide in patients with acute myocardial infarction. Circulation. 88 (1), 82-91.
20. MUKOYAMA M., NAKAO K., OHATA K., JOUIASAKI M., YOSHIMI'RA M., MORITA E., HOSODA K., SUGA S., OOAWA Y., YASI'K H. & IMURA H. (1991) Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun. 180,4.11-436
21. NAKAMURA M., KAWATA Y., YOSHIIJA H., ARAKAWA N.. KOFDA T., ICHIKAWA T., FIINAKOSHI T. & HIKAMDRI K. (1992) Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis. Am Heart J. 124 (5), 1283-1288.
22. NARUSK M., TAKEYAMA Y., TANABE A., HIROSHIGE J., N ARI'SE K., YOSHIMOTO T., TANAKA M., KATAUIRI T. & DEMURA H. (1994) Atrial and brain natriuretic peptides in cardiovascular diseases. Hypertension. 23 (1). I 231-4.
23. NEI.ESFN R. A., DtMSOALE J. E. & ZIEGLUR M. G. (1992) Plasma atrial natriuretic peptide is unstable under most storage conditions. Circulation. 86, 463-466.
24. RAINE A. E. G., ERNE P., BURGISSER E., MULLER F. B., BOLLI P., BURKART F. & BYHLF.R F. R. (1986) Atrial natriuretie peptide and atrial pressure in patients with congestive heart failure. N Engl J Med, 315 (9), 533-7.
25. SATO F., KAMOI K., WAKIYA Y., OZAWA T., ARAI O., ISHIBASHI M. & YAMAJI T. (1986) Relationship between plasma atrial natriuretic peptide levels and atrial pressure in man. J Clin Endocrin Metab, 63 (4), 823-827.
26. SCHAPER W. (1984) Experimental infarcts and the microcirculation. In: Therapeutic Approaches to Myocardial Infarct Size Limitation (eds Hearse D. Y. & Yellan D. M.), pp. 79-90. Raven Press, New York.
27. SMISETH O. A. & MJøS O. D. ( 1982) A reproducible and stable model of acute ischemic left ventricular failure in dogs. Clin Physiol., 2,225-239.
28. SUDOH T., KANCIAWA K., MINAMINO N. & MATSUO H. (1988) A new natriuretic peptide in porcine brain. Nature, 332,78-81.
29. SUNDSFJORD J. A., THIBAULT G., LAROCHEI.LE P. & CANTIN M. (1988) Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab, 66, 605-610.
30. WONG P. C, PRICE W, A., CHIU A. T., DUNCIA J. V., CARINI D. J.. WEXLER R. R.. JOHNSO, A. L. & TIMMEKMANS P. B. M. W. M. (1990) Nonpcptide angiotcnsin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP753, an orally active antihypertensive agent. J Pharm Exp Ther, 252 (2), 719-725.
31. YASUF, H., YOSHIMURA M., SUMIDA H., KlKDTA K., KUOIYAMA K.. JUUCIASAKl M., OciAWA H.. UKUMURA K., MUKOYAMA M. & NAKAO K. (1994) Localizalion and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation (1), 195-203.
32. YosHiMt1 RA M.. YASUE H., OKUMURA K.. OOAWA H., JOUGASAKI M., MUKOYAMA M., NAKAO K.. & IMUKA H. (1993) Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation, 87,464-469.